These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27506742)

  • 1. Effects of lifestyle intervention on left ventricular regional myocardial function in metabolic syndrome patients from the RESOLVE randomized trial.
    Serrano-Ferrer J; Crendal E; Walther G; Vinet A; Dutheil F; Naughton G; Lesourd B; Chapier R; Courteix D; Obert P
    Metabolism; 2016 Sep; 65(9):1350-60. PubMed ID: 27506742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right ventricle free wall mechanics in metabolic syndrome without type-2 diabetes: effects of a 3-month lifestyle intervention program.
    Serrano-Ferrer J; Walther G; Crendal E; Vinet A; Dutheil F; Naughton G; Lesourd B; Chapier R; Courteix D; Obert P
    Cardiovasc Diabetol; 2014 Aug; 13():116. PubMed ID: 25407698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between epicardial adipose tissue, high-sensitivity C-reactive protein and myocardial dysfunction in middle-aged men with suspected metabolic syndrome.
    Cho DH; Joo HJ; Kim MN; Lim DS; Shim WJ; Park SM
    Cardiovasc Diabetol; 2018 Jun; 17(1):95. PubMed ID: 29960588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of Improvement In Left Ventricular Diastolic Function Following a 1-Year Lifestyle Modification Program in Abdominally Obese Men with Features of the Metabolic Syndrome.
    Leclerc J; Arsenault M; Després JP; Brassard P; Gaudreault V; Bergeron J; Alméras N; Tremblay A; Auclair A; Ross MK; Denault-Bissonnette S; Poirier P
    Metab Syndr Relat Disord; 2016 Dec; 14(10):483-491. PubMed ID: 27754772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between epicardial adipose tissue thickness and adipo-fibrokine indicator profiles post-myocardial infarction.
    Gruzdeva O; Uchasova E; Dyleva Y; Borodkina D; Akbasheva O; Belik E; Karetnikova V; Brel N; Kokov A; Kashtalap V; Barbarash O
    Cardiovasc Diabetol; 2018 Mar; 17(1):40. PubMed ID: 29548286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of the metabolic syndrome in IGT subjects in a lifestyle intervention: results from the SLIM study.
    den Boer AT; Herraets IJ; Stegen J; Roumen C; Corpeleijn E; Schaper NC; Feskens E; Blaak EE
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1147-53. PubMed ID: 23462149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilevel Approach of a 1-Year Program of Dietary and Exercise Interventions on Bone Mineral Content and Density in Metabolic Syndrome--the RESOLVE Randomized Controlled Trial.
    Courteix D; Valente-dos-Santos J; Ferry B; Lac G; Lesourd B; Chapier R; Naughton G; Marceau G; João Coelho-e-Silva M; Vinet A; Walther G; Obert P; Dutheil F
    PLoS One; 2015; 10(9):e0136491. PubMed ID: 26376093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Epicardial Adipose Tissue, Left Ventricular Myocardial Fat Content, and Interstitial Fibrosis on Myocardial Contractile Function.
    Ng ACT; Strudwick M; van der Geest RJ; Ng ACC; Gillinder L; Goo SY; Cowin G; Delgado V; Wang WYS; Bax JJ
    Circ Cardiovasc Imaging; 2018 Aug; 11(8):e007372. PubMed ID: 30354491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of epicardial adipose tissue (EAT) thickness and anthropometric measurements in metabolic syndrome (MS) cases above and under the age of 65.
    Karadag B; Ozulu B; Ozturk FY; Oztekin E; Sener N; Altuntas Y
    Arch Gerontol Geriatr; 2011; 52(2):e79-84. PubMed ID: 20705350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diastolic functions and myocardial performance index in obese patients with or without metabolic syndrome: a tissue Doppler study.
    Koç F; Tokaç M; Kaya C; Kayrak M; Yazıcı M; Karabağ T; Vatankulu MA; Ayhan S; Demir K
    Turk Kardiyol Dern Ars; 2010 Sep; 38(6):400-4. PubMed ID: 21200118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of epicardial adipose tissue thickness by echocardiography and hypertension.
    Eroğlu S; Sade LE; Yıldırır A; Demir O; Müderrisoğlu H
    Turk Kardiyol Dern Ars; 2013 Mar; 41(2):115-22. PubMed ID: 23666298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epicardial Fat in Nonalcoholic Fatty Liver Disease: Properties and Relationships With Metabolic Factors, Cardiac Structure, and Cardiac Function.
    Psychari SN; Rekleiti N; Papaioannou N; Varhalama E; Drakoulis C; Apostolou TS; Iliodromitis EK
    Angiology; 2016 Jan; 67(1):41-8. PubMed ID: 25818101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired coronary flow reserve is associated with increased echocardiographic epicardial fat thickness in metabolic syndrome patients.
    Tok D; Çağli K; Kadife I; Turak O; Özcan F; Başar FN; Gölbaşi Z; Aydoğdu S
    Coron Artery Dis; 2013 May; 24(3):191-5. PubMed ID: 23291861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased epicardial adipose tissue in type 1 diabetes is associated with central obesity and metabolic syndrome.
    Momesso DP; Bussade I; Epifanio MA; Schettino CD; Russo LA; Kupfer R
    Diabetes Res Clin Pract; 2011 Jan; 91(1):47-53. PubMed ID: 21035889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of epicardial fat thickness to subclinical right ventricular dysfunction assessed by strain and strain rate imaging in subjects with metabolic syndrome: a two-dimensional speckle tracking echocardiography study.
    Gökdeniz T; Erkol A; Kalaycıoğlu E; Çağrı Aykan A; Gül İ; Boyacı F; Turan B; Ozkan M
    Echocardiography; 2015 Feb; 32(2):248-56. PubMed ID: 24815416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of carbohydrate versus fat restriction on serum levels of adipocytokines, markers of inflammation, and endothelial function among women with the metabolic syndrome: a randomized cross-over clinical trial.
    Rajaie S; Azadbakht L; Saneei P; Khazaei M; Esmaillzadeh A
    Ann Nutr Metab; 2013; 63(1-2):159-67. PubMed ID: 24021709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease.
    Navaneethan SD; Fealy CE; Scelsi AC; Arrigain S; Malin SK; Kirwan JP
    Am J Nephrol; 2015; 42(4):274-81. PubMed ID: 26495987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.
    Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; O'Moore-Sullivan T; Marwick TH
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1239-49. PubMed ID: 22172779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.
    You T; Yang R; Lyles MF; Gong D; Nicklas BJ
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E741-7. PubMed ID: 15562250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.